Form 4 Tracker
John M. Evans

Director, CEO · 4 filings · Latest: Jun 29, 2026

Beam Therapeutics Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
BEAM
John M. EvansDirector, CEOJun 30, 2026
Sale
$34.3125,000$857.7K1,047,205
BEAM
John M. EvansDirector, CEOJun 30, 2026
Option Exercise
$1.0325,000$25.8K1,072,205
BEAM
John M. EvansDirector, CEOJun 29, 2026
Sale
$35.4925,000$887.4K1,047,205
BEAM
John M. EvansDirector, CEOJun 29, 2026
Option Exercise
$0.761325,000$19.0K1,072,205
BEAM
JOHN M EVANSJun 30, 2026
Proposed Sale
$34.3125,000$857.7K
BEAM
JOHN M EVANSJun 29, 2026
Proposed Sale
$35.4925,000$887.4K
BEAM
John M. EvansDirector, CEOApr 1, 2026
Sale
$24.5830,078$739.3K1,047,205
BEAM
John M. EvansDirector, CEOMar 31, 2026
Sale
$22.7625,000$569.1K986,667
BEAM
John M. EvansDirector, CEOMar 31, 2026
Option Exercise
$0.6725,000$16.8K1,011,667
BEAM
John M. EvansDirector, CEOMar 30, 2026
Sale
$22.3725,000$559.2K986,667
BEAM
John M. EvansDirector, CEOMar 30, 2026
Option Exercise
$0.6725,000$16.8K1,011,667
BEAM
JOHN M. EVANSApr 2, 2026
Proposed Sale
$21.9066,874$1.5M
BEAM
JOHN M EVANSMar 31, 2026
Proposed Sale
$22.7625,000$569.1K
BEAM
JOHN M EVANSMar 30, 2026
Proposed Sale
$22.3725,000$559.2K
BEAM
John M. EvansDirector, CEOJan 30, 2026
Sale
$28.3625,000$708.9K986,667
BEAM
John M. EvansDirector, CEOJan 30, 2026
Option Exercise
$0.6725,000$16.8K1,011,667
BEAM
John M. EvansDirector, CEOJan 29, 2026
Sale
$29.3825,000$734.6K986,667
BEAM
John M. EvansDirector, CEOJan 29, 2026
Option Exercise
$0.6725,000$16.8K1,011,667
BEAM
JOHN M EVANSJan 30, 2026
Proposed Sale
$28.3625,000$708.9K
BEAM
JOHN M EVANSJan 29, 2026
Proposed Sale
$29.3825,000$734.6K

Page 1 of 2

Next →